Stock listing
Veradermics, Incorporated
Selected listing: MANE · NYSE · USD · US
Veradermics, Incorporated (NYSE:MANE), Health Technology. Latest release Sep 3, 2026: Veradermics to Present at Upcoming September Investor Conferences.
- Ticker
- NYSE:MANE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE
- Currency
- USD
About Veradermics, Incorporated
The company focuses on innovative solutions in its industry, positioning itself as a key player in the market. Veradermics aims to leverage its expertise to drive growth and enhance shareholder value.
Latest news from Veradermics, Incorporated
Veradermics to Present at Upcoming September Investor Conferences
September 3, 2026
Veradermics Reports Second Quarter 2026 Financial Results and Highlights Recent Corporate and Clinical Progress
August 11, 2026
Veradermics Announces Presentations of Data from a Subgroup Analysis of Phase 2/3 Study ‘302’ in Males with Pattern Hair Loss at 2026 American Academy of Dermatology Innovation Academy
July 17, 2026
Veradermics’ Oral VDPHL01 Delivers Positive Study ‘207’ Phase 2 Clinical Trial Results in Female Pattern Hair Loss Ahead of Upcoming Phase 2/3 Study ‘306’ Readout
July 15, 2026
Veradermics to Hold Conference Call to Discuss Study ‘207’ Phase 2 Clinical Trial Results of VDPHL01 in Females with Mild-to-Moderate Pattern Hair Loss
July 14, 2026
Research Veradermics, Incorporated
Veradermics, Incorporated company profile
View the public company page for Veradermics, Incorporated on 6ix.
Veradermics, Incorporated news
Read company news and market updates connected to Veradermics, Incorporated.
Veradermics, Incorporated investor events
Find investor webinars, events, and replay context for Veradermics, Incorporated.